
Honorary Award for the Fourth Consecutive Year: Y-Logimed Recognized by Abbott Medical for Outstanding Performance
Y-Logimed, a member of the Hellenic Healthcare Group (HHG), has been honored for the fourth consecutive year by Abbott Medical at the EMEA Hybrid Sales Award Meeting 2025, held on January 12–14, 2026, in Dubai, United Arab Emirates (UAE).
This recognition highlights Y-Logimed’s outstanding performance and strong collaboration with Abbott Medical, reaffirming their shared commitment to growth, innovation, quality, and meaningful support for healthcare professionals.
Throughout 2025, Y-Logimed further strengthened its growth momentum, implementing targeted training and education initiatives across Greece, within the framework of scientific congresses, events and collaborations. A series of training sessions and workshops with a strong hands-on focus was delivered to physicians and healthcare professionals, promoting knowledge exchange and practical familiarization with applications aligned with day-to-day needs in cardiac catheterization laboratory settings. Within this context, Y-Logimed showcased the Abbott Medical portfolio and technologies available in the Greek market, focusing on the appropriate selection and use of the available technologies for each clinical case, applying best-practices (technique, workflow, troubleshooting), ensuring consistent and safe application, and facilitating knowledge-sharing, grounded in clinical experience. Key areas of focus included the Diamondback & Stealth 360™ Orbital Atherectomy System, Optical Coherence Tomography (OCT), and physiologic assessment technologies for Fractional Flow Reserve (FFR), Coronary Flow Reserve (CFR) and microcirculation (IMR) assessment using the thermodilution method.
Since 2014, Y-Logimed has been the official distributor of Abbott Medical in Greece. Through this long-standing partnership, Y-Logimed offers an extensive portfolio of cutting-edge Abbott Medical products, supporting coronary and peripheral interventions, as well as solutions used in interventional radiology and vascular surgery, while continuously investing in its people, training, and high-quality field technical support for its partners.





